<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FB5D6522-20EB-4EF7-B531-9DACC59C5706"><gtr:id>FB5D6522-20EB-4EF7-B531-9DACC59C5706</gtr:id><gtr:name> University of Pavia</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FB5D6522-20EB-4EF7-B531-9DACC59C5706"><gtr:id>FB5D6522-20EB-4EF7-B531-9DACC59C5706</gtr:id><gtr:name> University of Pavia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/572042EC-CCDD-43EC-ADA9-8ECA3B62C42B"><gtr:id>572042EC-CCDD-43EC-ADA9-8ECA3B62C42B</gtr:id><gtr:firstName>Gerard</gtr:firstName><gtr:surname>Graham</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CCA3449A-E512-4E70-83E1-36F294C2D0AF"><gtr:id>CCA3449A-E512-4E70-83E1-36F294C2D0AF</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Nibbs</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3E91007A-C382-4933-9141-61911A5056ED"><gtr:id>3E91007A-C382-4933-9141-61911A5056ED</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Garside</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0901113"><gtr:id>67D21936-C1BB-4308-85F5-4382C7F7FEC0</gtr:id><gtr:title>Regulation of the adaptive immune response by chemokine scavenging receptors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901113</gtr:grantReference><gtr:abstractText>When our bodies are invaded by foreign organisms such as bacteria or viruses, we mount what is called an immune response. This requires the careful orchestration of cell movement throughout the body, without which the immune response would not be properly developed. Much of the movement of the immune cells is regulated by specialised proteins which are called Chemokines. It is with these proteins that we work. We have identified molecules that can degrade some of the chemokines and therefore remove them from the area surrounding cells. We believe that this is important for the proper working of the immune system. The current proposal aims to study these molecules, which we call scavengers, in much more detail and to carefully examine their roles in helping the development of immune responses. The data we generate will therefore help us to understand the regulation of the immune response in much more detail and will have implications for our ability to therapeutically manipulate this process. In addition, sometimes chemokines can play deleterious roles and can be at the root cause of diseases such as arthritis and psoriasis. We believe that we might be able to use these scavenger molecules in disease contexts to switch off inflammation. We will therefore try to develop anti-inflammatory agents based on our knowledge of these scavenger molecules and will partner with a large Pharmaceutical company to help develop their therapeutic potential.</gtr:abstractText><gtr:technicalSummary>Over the past 20 years much has been learnt about the fundamental roles played by chemokines and their receptors in regulating immune responses. We have been particularly interested in a subfamily of chemokine receptors which are characterised by promiscuous ligand binding and by an apparent inability to signal following ligand binding. Currently there are 4 members of this atypical chemokine receptor family and we have been instrumental in the identification and characterisation of 2 of these namely D6 and CCXCKR. Essentially, both are scavenger receptors, binding and internalising chemokine ligands and targeting them for intracellular degradation. D6 binds all the inflammatory CC chemokines and CCXCKR, in a complementary manner, binds the key homeostatic CC chemokines. These are therefore negative regulators of CC chemokine biology the identification of which has marked a major shift in our understanding of chemokine biology. Our studies on D6 indicate that it plays a strong role in regulating inflammatory responses in vivo. However, our more recent data suggest broader roles for D6 specifically in the context of regulation of adaptive immune responses. The ligand binding profile of CCXCKR immediately implicates it in adaptive immunity and thus we propose that these 2 atypical receptors represent a novel and important axis in the orchestration of the in vivo immune response. We now propose to unify our studies into D6 and CCXCKR under a single programme. We will use shared technologies to carefully investigate their roles in regulating chemokine availability, leukocyte migration and movement and the impact of this on adaptive immune responses. In addition, we have seen that an N terminal fragment of D6 retains the ability to bind chemokines. Given the promiscuity of D6 and its ability to bind all inflammatory CC chemokines, this N terminal peptide may represent a valuable therapeutic agent. We therefore also propose to initiate studies into the usefulness of chemokine scavenger receptor derived peptides as therapeutic agents. In the first instance, this will involve a biochemical analysis of the D6 N-terminal peptide as well as in vivo analyses of its ability to block inflammation in murine models. In addition, we will partner with colleagues at Novartis to develop the therapeutic potential of the D6 N-terminal peptide.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-31</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1736567</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pavia</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Rheumatology and Translational Immunology Research Laboratories [LaRIT]</gtr:department><gtr:description>miRNA studies in rheumatoid arthritis</gtr:description><gtr:id>9E7373DE-49BA-469D-A0E5-8003A0685C30</gtr:id><gtr:impact>Kurowska-Stolarska, M., Alivernini, S., Ballantine, L.E., Asquith, D.L., Millar, N.L., Gilchrist, D.S., Reilly, J., Ierna, M., Fraser, A.R., Stolarski, B., et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 108, 11193-11198.</gtr:impact><gtr:partnerContribution>Initiating miRNA studies in the group.Initiated studies into D6 and Systemic Sclerosis.</gtr:partnerContribution><gtr:piContribution>Development of technolgies for gene expression analysis in small numbers of cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:department><gtr:description>Atypical chemokine receptors in West Nile Virus Infection</gtr:description><gtr:id>14034DA2-D235-41F1-A71F-8F43235F7467</gtr:id><gtr:impact>Nothing yet.</gtr:impact><gtr:partnerContribution>Initiating studies into West Nile Virus</gtr:partnerContribution><gtr:piContribution>Intitiation of collaboration to study the impact of D6 defficiency on responsiveness of mice to West Nile Virus infection.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection, Immunity and Inflammation</gtr:department><gtr:description>miRNA studies in rheumatoid arthritis</gtr:description><gtr:id>776B20E4-9B52-4BB6-BAFC-82A9D67E599B</gtr:id><gtr:impact>Kurowska-Stolarska, M., Alivernini, S., Ballantine, L.E., Asquith, D.L., Millar, N.L., Gilchrist, D.S., Reilly, J., Ierna, M., Fraser, A.R., Stolarski, B., et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 108, 11193-11198.</gtr:impact><gtr:partnerContribution>Initiating miRNA studies in the group.Initiated studies into D6 and Systemic Sclerosis.</gtr:partnerContribution><gtr:piContribution>Development of technolgies for gene expression analysis in small numbers of cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Glasgow University Open Days</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A61D6CA3-89B8-45F8-9B56-C7B86FCA84EE</gtr:id><gtr:impact>Promotion of Glasgow University's research and teaching to ~100 prospective students and their parents.

Increase in interest in studying Immunology at Glasgow University.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.gla.ac.uk/about/visit/opendays/</gtr:url><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Undergraduate teaching</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F32431AF-D149-42F7-8742-90F7B575ED13</gtr:id><gtr:impact>Co-ordination of final year undergraduate Immunology course at Glasgow University, plus presentations on immunology and cancer/inflammation to ~80 third and fourth year undergraduate students every year. Dissemination of own research findings presented in the broader context of the field.

Education of local young people. Each year 10-12 Immunology graduates undertake PhD studies, with others entering Masters studies or other courses (Medicine, Dentistry, Vet Medicine).</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of the Glasgow Science Centre Scientific Advisory Panel</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D852256A-6DC6-4974-BB4C-C20CAE273E0B</gtr:id><gtr:impact>Providing advice on direction etc for Glasgow Science Centre

Regular invitee to present talks at the Science Centre.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Big Biology Day 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9DDDF3E7-3BB0-41DE-9084-DC2669B175AA</gtr:id><gtr:impact>Talk informed about the history and mechanisms of vaccination

Further requests for presentations at local schools</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.societyofbiology.org/get-involved/biologyweek/big-biology-days</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primary School Science Fair (2012)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1896A22E-A3DC-43C9-BEC4-68310773F97E</gtr:id><gtr:impact>100 primary school children and their parents attended a science fair entitled 'Science Rocks' at which I ran an interactive workshop on the history and mechanisms of vaccination.

Feedback was excellent and further 'Science Rocks' events are planned in the local area.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alumni Networking</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0C8FD832-C91A-497B-BF3A-9DA510382342</gtr:id><gtr:impact>Establishment of a Facebook networking site for alumni of Glasgow University's Immunology BSc course.

~300 alumni connected via social media and a site to advertise and disseminate job and postgraduate opportunities in Glasgow, UK, and internationally. Source of individuals to provide advice, and act as contacts, for current final year students.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker Konstanz</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4FAD4EF6-C537-447B-80EE-9865018F6BB2</gtr:id><gtr:impact>Invited seminar at University of Konstanz, Germany

Increased European research profile</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School talks</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>071AF595-4AEF-465E-AFE1-79C7654A0C49</gtr:id><gtr:impact>120 pupils attended a talk on my research

School pupils visit the lab for placements and to carry out their 6th year projects.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2CB378D6-D319-415D-9939-907CFD5F85B5"><gtr:id>2CB378D6-D319-415D-9939-907CFD5F85B5</gtr:id><gtr:title>Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/df04e8959509b9f44ae9428a0656f9b1"><gtr:id>df04e8959509b9f44ae9428a0656f9b1</gtr:id><gtr:otherNames>Graham AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F882E38D-CC03-4011-A037-83297EDA52C6"><gtr:id>F882E38D-CC03-4011-A037-83297EDA52C6</gtr:id><gtr:title>The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af864607240255e91efccd46a80dec8d"><gtr:id>af864607240255e91efccd46a80dec8d</gtr:id><gtr:otherNames>Ulvmar MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30117027-26D8-4A2B-8516-6B5466134DE6"><gtr:id>30117027-26D8-4A2B-8516-6B5466134DE6</gtr:id><gtr:title>An analysis of the function and expression of D6 on lymphatic endothelial cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D34BC7D1-DE94-4CF7-91A2-07E143E00EA9"><gtr:id>D34BC7D1-DE94-4CF7-91A2-07E143E00EA9</gtr:id><gtr:title>ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5526a5b6dd20ea8e6a2e7e7869f29962"><gtr:id>5526a5b6dd20ea8e6a2e7e7869f29962</gtr:id><gtr:otherNames>Bryce SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0288509F-7F22-43A2-BD4A-CC0B476D1176"><gtr:id>0288509F-7F22-43A2-BD4A-CC0B476D1176</gtr:id><gtr:title>Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8746fb85801997fdc64d246604e7e1e"><gtr:id>a8746fb85801997fdc64d246604e7e1e</gtr:id><gtr:otherNames>Rot A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C468A14-ABE8-4986-A502-84386E6B7064"><gtr:id>4C468A14-ABE8-4986-A502-84386E6B7064</gtr:id><gtr:title>An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C8CD0542-43CD-4C25-A01B-8DEBD29551E2"><gtr:id>C8CD0542-43CD-4C25-A01B-8DEBD29551E2</gtr:id><gtr:title>Immune regulation by atypical chemokine receptors</gtr:title><gtr:parentPublicationTitle>Nature Reviews Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4552c4eea41886c50aad254d85f22bef"><gtr:id>4552c4eea41886c50aad254d85f22bef</gtr:id><gtr:otherNames>Nibbs R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66CE8D3C-E684-4A0C-AA5F-AA4A8D4181DE"><gtr:id>66CE8D3C-E684-4A0C-AA5F-AA4A8D4181DE</gtr:id><gtr:title>Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8746fb85801997fdc64d246604e7e1e"><gtr:id>a8746fb85801997fdc64d246604e7e1e</gtr:id><gtr:otherNames>Rot A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B4F19D9-7B46-428C-BC00-1EE438A7537C"><gtr:id>2B4F19D9-7B46-428C-BC00-1EE438A7537C</gtr:id><gtr:title>Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e71e435ee193f5c5787b32226caf7061"><gtr:id>e71e435ee193f5c5787b32226caf7061</gtr:id><gtr:otherNames>Mori M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C09DB33E-C937-4B51-A59A-E327A65755CB"><gtr:id>C09DB33E-C937-4B51-A59A-E327A65755CB</gtr:id><gtr:title>Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8e8e17f1e5edb480922615a7b2762b33"><gtr:id>8e8e17f1e5edb480922615a7b2762b33</gtr:id><gtr:otherNames>Patterson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8FEA7561-361D-4687-B8D6-6BEB254AAA98"><gtr:id>8FEA7561-361D-4687-B8D6-6BEB254AAA98</gtr:id><gtr:title>The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells.</gtr:title><gtr:parentPublicationTitle>Journal of hematology &amp; oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f68c89256db1a07360471b958535e08"><gtr:id>0f68c89256db1a07360471b958535e08</gtr:id><gtr:otherNames>Halsey C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1756-8722</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF7C672D-C934-4444-A142-8E88BA67DCF0"><gtr:id>AF7C672D-C934-4444-A142-8E88BA67DCF0</gtr:id><gtr:title>New nomenclature for atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09671B07-BD21-4C3B-B6D7-1108229A85F1"><gtr:id>09671B07-BD21-4C3B-B6D7-1108229A85F1</gtr:id><gtr:title>Defining the chemokine basis for leukocyte recruitment during viral encephalitis.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/01c8f238822570a1dda32bf9d418f71e"><gtr:id>01c8f238822570a1dda32bf9d418f71e</gtr:id><gtr:otherNames>Michlmayr D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DEF7C866-FEB0-4339-9C56-02C866B4F086"><gtr:id>DEF7C866-FEB0-4339-9C56-02C866B4F086</gtr:id><gtr:title>CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2ddf28a176bf0f756427edbddb9f2ee"><gtr:id>e2ddf28a176bf0f756427edbddb9f2ee</gtr:id><gtr:otherNames>Lucas B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C6A495B-B48F-4192-BBEB-BB1DEDDA8147"><gtr:id>3C6A495B-B48F-4192-BBEB-BB1DEDDA8147</gtr:id><gtr:title>ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5526a5b6dd20ea8e6a2e7e7869f29962"><gtr:id>5526a5b6dd20ea8e6a2e7e7869f29962</gtr:id><gtr:otherNames>Bryce SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C6AFB54-7FDE-4953-AAD1-FAEC1CA0593A"><gtr:id>1C6AFB54-7FDE-4953-AAD1-FAEC1CA0593A</gtr:id><gtr:title>The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7fa6aacd5bad30d3a40924dd32a40426"><gtr:id>7fa6aacd5bad30d3a40924dd32a40426</gtr:id><gtr:otherNames>Hansell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E77C3D3-9211-4789-9A68-3174CAFD1B05"><gtr:id>3E77C3D3-9211-4789-9A68-3174CAFD1B05</gtr:id><gtr:title>An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0150EF46-2BDA-46D1-AB9F-0B0570A11A7F"><gtr:id>0150EF46-2BDA-46D1-AB9F-0B0570A11A7F</gtr:id><gtr:title>Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea9c4de01f2e83219464ff6b6da38de9"><gtr:id>ea9c4de01f2e83219464ff6b6da38de9</gtr:id><gtr:otherNames>Ford LB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1ED02D33-725A-4728-89CB-6A1F116CF94B"><gtr:id>1ED02D33-725A-4728-89CB-6A1F116CF94B</gtr:id><gtr:title>Cardiac allograft rejection: examination of the expression and function of the decoy chemokine receptor D6.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d9edfb4b126fa9c8befd0babd299f2f"><gtr:id>4d9edfb4b126fa9c8befd0babd299f2f</gtr:id><gtr:otherNames>Bradford L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76FD38B2-E776-4196-B741-EB55C9F7FBA7"><gtr:id>76FD38B2-E776-4196-B741-EB55C9F7FBA7</gtr:id><gtr:title>Targeting cell migration in rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Current opinion in rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8c81b946dab25d016d4ae274f7b8944"><gtr:id>a8c81b946dab25d016d4ae274f7b8944</gtr:id><gtr:otherNames>Asquith DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-8711</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF730C46-F913-43D3-90AC-B51BC16CF999"><gtr:id>DF730C46-F913-43D3-90AC-B51BC16CF999</gtr:id><gtr:title>Acute inflammatory response to cobalt chromium orthopaedic wear debris in a rodent air-pouch model.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/994fe14f637366421df74fbfd4ed6977"><gtr:id>994fe14f637366421df74fbfd4ed6977</gtr:id><gtr:otherNames>Akbar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD85AEF6-36A4-42D7-A18A-D03A5C260C55"><gtr:id>BD85AEF6-36A4-42D7-A18A-D03A5C260C55</gtr:id><gtr:title>The biochemistry and biology of the atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f176dd01922419b3d1012bc2a4437f53"><gtr:id>f176dd01922419b3d1012bc2a4437f53</gtr:id><gtr:otherNames>Graham GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43AE4FA1-4ADD-496E-B02C-F5C958261E66"><gtr:id>43AE4FA1-4ADD-496E-B02C-F5C958261E66</gtr:id><gtr:title>Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3c08a4f56da875433b0ef01ef232b551"><gtr:id>3c08a4f56da875433b0ef01ef232b551</gtr:id><gtr:otherNames>Williams MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/10C72B0D-746C-4772-B1B3-4438546F3F1D"><gtr:id>10C72B0D-746C-4772-B1B3-4438546F3F1D</gtr:id><gtr:title>MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c46e2ecdbdcf081c5e7884ac05702bb5"><gtr:id>c46e2ecdbdcf081c5e7884ac05702bb5</gtr:id><gtr:otherNames>Kurowska-Stolarska M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE531B54-12E9-42CF-8A4F-EB3151E60C9F"><gtr:id>DE531B54-12E9-42CF-8A4F-EB3151E60C9F</gtr:id><gtr:title>D6: the 'crowd controller' at the immune gateway.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0331f9f7036ea49437976540ae3a31b"><gtr:id>f0331f9f7036ea49437976540ae3a31b</gtr:id><gtr:otherNames>Lee KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D48D69A1-6BB0-4440-ACF5-642E8F8EC767"><gtr:id>D48D69A1-6BB0-4440-ACF5-642E8F8EC767</gtr:id><gtr:title>Adult human glia, pericytes and meningeal fibroblasts respond similarly to IFNy but not to TGF?1 or M-CSF.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f36a0f1f27651c2f7085c8fa36a16c8"><gtr:id>0f36a0f1f27651c2f7085c8fa36a16c8</gtr:id><gtr:otherNames>Smith AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ECCD3C35-FB39-42D4-92D3-7512D079CBE9"><gtr:id>ECCD3C35-FB39-42D4-92D3-7512D079CBE9</gtr:id><gtr:title>Atypical chemokine receptor ACKR2 mediates chemokine scavenging by primary human trophoblasts and can regulate fetal growth, placental structure, and neonatal mortality in mice.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4eef6426f9dbf1ffeb4bd3b5c4b5a7ff"><gtr:id>4eef6426f9dbf1ffeb4bd3b5c4b5a7ff</gtr:id><gtr:otherNames>Teoh PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53587449-BBEE-4BC0-8453-5834DF595CC8"><gtr:id>53587449-BBEE-4BC0-8453-5834DF595CC8</gtr:id><gtr:title>The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3c08a4f56da875433b0ef01ef232b551"><gtr:id>3c08a4f56da875433b0ef01ef232b551</gtr:id><gtr:otherNames>Williams MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1D241DE-C0E2-41E6-B38F-266CF973013F"><gtr:id>A1D241DE-C0E2-41E6-B38F-266CF973013F</gtr:id><gtr:title>IL-33 promotes ST2-dependent lung fibrosis by the induction&amp;nbsp;of alternatively activated macrophages and innate&amp;nbsp;lymphoid cells in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/710A88B6-24AE-42B8-98D3-978913F80DB0"><gtr:id>710A88B6-24AE-42B8-98D3-978913F80DB0</gtr:id><gtr:title>International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Pharmacological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-6997</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40B9CE8B-BC13-41E9-A0A2-2D209E593A35"><gtr:id>40B9CE8B-BC13-41E9-A0A2-2D209E593A35</gtr:id><gtr:title>An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3c522c0940f405dc5917be0f61125ff"><gtr:id>a3c522c0940f405dc5917be0f61125ff</gtr:id><gtr:otherNames>Codullo V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0129335D-DF34-456E-BFC3-BBFA393E2A38"><gtr:id>0129335D-DF34-456E-BFC3-BBFA393E2A38</gtr:id><gtr:title>IL-33 induces skin inflammation with mast cell and neutrophil activation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/886abf362db80f502c90ad76ccc80c2e"><gtr:id>886abf362db80f502c90ad76ccc80c2e</gtr:id><gtr:otherNames>Hueber AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79E9F35F-4C9A-4AD7-A7AA-40B700F36CBA"><gtr:id>79E9F35F-4C9A-4AD7-A7AA-40B700F36CBA</gtr:id><gtr:title>The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0331f9f7036ea49437976540ae3a31b"><gtr:id>f0331f9f7036ea49437976540ae3a31b</gtr:id><gtr:otherNames>Lee KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F75F86DD-5F74-4554-B112-43A0B32680AE"><gtr:id>F75F86DD-5F74-4554-B112-43A0B32680AE</gtr:id><gtr:title>Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7fa6aacd5bad30d3a40924dd32a40426"><gtr:id>7fa6aacd5bad30d3a40924dd32a40426</gtr:id><gtr:otherNames>Hansell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9EA3E829-55CE-477B-9025-392A9D4F0F4A"><gtr:id>9EA3E829-55CE-477B-9025-392A9D4F0F4A</gtr:id><gtr:title>The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3fe90aa147fd837da2ded27ba372cb11"><gtr:id>3fe90aa147fd837da2ded27ba372cb11</gtr:id><gtr:otherNames>Hewit KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A208DA9-1439-4227-B947-0DD5D5993B3E"><gtr:id>3A208DA9-1439-4227-B947-0DD5D5993B3E</gtr:id><gtr:title>The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0331f9f7036ea49437976540ae3a31b"><gtr:id>f0331f9f7036ea49437976540ae3a31b</gtr:id><gtr:otherNames>Lee KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DDEA7DF6-1E11-4D01-AA78-DFC9822A5642"><gtr:id>DDEA7DF6-1E11-4D01-AA78-DFC9822A5642</gtr:id><gtr:title>International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Pharmacological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-6997</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3967944-54A1-4D93-A313-FFC5B41D1CA7"><gtr:id>E3967944-54A1-4D93-A313-FFC5B41D1CA7</gtr:id><gtr:title>Roundabout 1 exists predominantly as a basal dimeric complex and this is unaffected by binding of the ligand Slit2.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/56b5789bc5a573cf9559163b8133b97d"><gtr:id>56b5789bc5a573cf9559163b8133b97d</gtr:id><gtr:otherNames>Zakrys L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9FD214EF-A097-4443-8905-547267A44BA8"><gtr:id>9FD214EF-A097-4443-8905-547267A44BA8</gtr:id><gtr:title>Immune regulation by atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f44f77c5f39fcdf6895683c985d7c41b"><gtr:id>f44f77c5f39fcdf6895683c985d7c41b</gtr:id><gtr:otherNames>Nibbs RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B65A0055-9277-43E9-A8FC-E9978ADD4137"><gtr:id>B65A0055-9277-43E9-A8FC-E9978ADD4137</gtr:id><gtr:title>Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f176dd01922419b3d1012bc2a4437f53"><gtr:id>f176dd01922419b3d1012bc2a4437f53</gtr:id><gtr:otherNames>Graham GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DCD9F8EE-A30F-4D03-8AFA-3CB4FC9D0E14"><gtr:id>DCD9F8EE-A30F-4D03-8AFA-3CB4FC9D0E14</gtr:id><gtr:title>The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3fe90aa147fd837da2ded27ba372cb11"><gtr:id>3fe90aa147fd837da2ded27ba372cb11</gtr:id><gtr:otherNames>Hewit KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D37F2F5-605D-4B13-9E79-563F3CA41765"><gtr:id>7D37F2F5-605D-4B13-9E79-563F3CA41765</gtr:id><gtr:title>An analysis of the function and expression of D6 on lymphatic endothelial cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C32A56F5-A8C9-4787-8950-0D5042694D62"><gtr:id>C32A56F5-A8C9-4787-8950-0D5042694D62</gtr:id><gtr:title>D6/ACKR2.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f176dd01922419b3d1012bc2a4437f53"><gtr:id>f176dd01922419b3d1012bc2a4437f53</gtr:id><gtr:otherNames>Graham GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C4A6281-2897-4E22-8B21-7E87DAB9965F"><gtr:id>2C4A6281-2897-4E22-8B21-7E87DAB9965F</gtr:id><gtr:title>CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/62da6c354b9cdbfdf4562f4836cfe2bd"><gtr:id>62da6c354b9cdbfdf4562f4836cfe2bd</gtr:id><gtr:otherNames>Bunting MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B1FBC23-1196-4189-A6E9-7C792BE7D196"><gtr:id>5B1FBC23-1196-4189-A6E9-7C792BE7D196</gtr:id><gtr:title>Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c042d7437f5460e147b6334c0038e322"><gtr:id>c042d7437f5460e147b6334c0038e322</gtr:id><gtr:otherNames>Baldwin HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D75CAFC5-943C-4CC2-9195-768A6561B13C"><gtr:id>D75CAFC5-943C-4CC2-9195-768A6561B13C</gtr:id><gtr:title>Flow cytometry applications for the analysis of chemokine receptor expression and function.</gtr:title><gtr:parentPublicationTitle>Cytometry. Part A : the journal of the International Society for Analytical Cytology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dbbfd599946cdd5577a09fd121712634"><gtr:id>dbbfd599946cdd5577a09fd121712634</gtr:id><gtr:otherNames>Anselmo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-4922</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/427B07BA-14E0-409A-BCD6-F4BDE691D63B"><gtr:id>427B07BA-14E0-409A-BCD6-F4BDE691D63B</gtr:id><gtr:title>D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0331f9f7036ea49437976540ae3a31b"><gtr:id>f0331f9f7036ea49437976540ae3a31b</gtr:id><gtr:otherNames>Lee KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B9C275B8-15B2-49AB-951F-6CC17D923FE2"><gtr:id>B9C275B8-15B2-49AB-951F-6CC17D923FE2</gtr:id><gtr:title>New nomenclature for atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/870D886B-CA40-4E57-8CC6-BC24343AE6AE"><gtr:id>870D886B-CA40-4E57-8CC6-BC24343AE6AE</gtr:id><gtr:title>ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5526a5b6dd20ea8e6a2e7e7869f29962"><gtr:id>5526a5b6dd20ea8e6a2e7e7869f29962</gtr:id><gtr:otherNames>Bryce SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E7E3ACF3-E07F-4AB9-9BF2-F2CB1A862174"><gtr:id>E7E3ACF3-E07F-4AB9-9BF2-F2CB1A862174</gtr:id><gtr:title>Suppression, subversion and escape: the role of regulatory T cells in cancer progression.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8fa102c8eaf2fe2223529d6199ce916c"><gtr:id>8fa102c8eaf2fe2223529d6199ce916c</gtr:id><gtr:otherNames>Oleinika K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3B2FA16A-ABAD-4B67-81A0-C6A547C006FC"><gtr:id>3B2FA16A-ABAD-4B67-81A0-C6A547C006FC</gtr:id><gtr:title>Chemokines as novel and versatile reagents for flow cytometry and cell sorting.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/892bc3e8d2177b53d5cb2f718431be5c"><gtr:id>892bc3e8d2177b53d5cb2f718431be5c</gtr:id><gtr:otherNames>Le Brocq ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FE133F3-AEFB-4E40-B7BF-7D4C4A10889C"><gtr:id>7FE133F3-AEFB-4E40-B7BF-7D4C4A10889C</gtr:id><gtr:title>Chemokines as novel and versatile reagents for flow cytometry and cell sorting.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/892bc3e8d2177b53d5cb2f718431be5c"><gtr:id>892bc3e8d2177b53d5cb2f718431be5c</gtr:id><gtr:otherNames>Le Brocq ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901113</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>